18 assets in Progesterone-Receptor Negative Breast Cancer

Therapeutic assets addressing Progesterone-Receptor Negative Breast Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Carboplatin Progesterone-Receptor Negative Breast Cancer	Northwestern University	P3	BBB (72)
Epirubicin Progesterone-Receptor Negative Breast Cancer	Massachusetts General Hospital	P2	BB (71)
Pembrolizumab Progesterone-Receptor Negative Breast Cancer	Massachusetts General Hospital	P2	BB (71)
Cyclophosphamide Progesterone-Receptor Negative Breast Cancer	Massachusetts General Hospital	P3	BB (70)
Adriamycin Progesterone-Receptor Negative Breast Cancer	Roswell Park Cancer Institute	P3	BB (68)
Capecitabine Progesterone-Receptor Negative Breast Cancer	M.D. Anderson Cancer Center	P3	BB (68)
Cis-Diamminedichloroplatinum Ii Progesterone-Receptor Negative Breast Cancer	University of Washington	P3	BB (68)
Trastuzumab Progesterone-Receptor Negative Breast Cancer	Jules Bordet Institute	P2	B (57)
Decitabine Progesterone-Receptor Negative Breast Cancer	Virginia Commonwealth University	P2	CCC (53)
Fes F-18 Progesterone-Receptor Negative Breast Cancer	National Cancer Institute (NCI)	P2	CCC (53)
Panitumumab Progesterone-Receptor Negative Breast Cancer	M.D. Anderson Cancer Center	P2	CCC (53)
Pertuzumab Progesterone-Receptor Negative Breast Cancer	Jules Bordet Institute	P2	CCC (53)
Trastuzumab Emtansine Progesterone-Receptor Negative Breast Cancer	Jules Bordet Institute	P2	CCC (53)
Olaparib Progesterone-Receptor Negative Breast Cancer	OHSU Knight Cancer Institute	P1	CC (47)
Capivasertib Progesterone-Receptor Negative Breast Cancer	M.D. Anderson Cancer Center	P1	CC (43)
Modified Vaccinia Virus Ankara Vaccine Expressing P53 Progesterone-Receptor Negative Breast Cancer	City of Hope Medical Center	P1	CC (43)
Vistusertib Progesterone-Receptor Negative Breast Cancer	M.D. Anderson Cancer Center	P1	CC (43)
Technetium Tc 99M Sestamibi Progesterone-Receptor Negative Breast Cancer	M.D. Anderson Cancer Center	Early P1	C (39)